Teleflex, a leading global provider of medical devices for critical care and surgery, has acquired privately held Nostix, a Boulder, Colorado developer of innovative tip confirmation systems that are used to increase the accuracy of vascular access device placement.
Currently, Nostix’s ECG-only system is being marketed in the United States for use in placement of peripherally inserted central catheters (PICC) and is used as an alternative to X-ray confirmation in adult patients.
"Adding the Nostix product line provides our customers with the ability to implement catheter tip placement solutions that meet their specific therapeutic and budget needs," said Benson Smith, Chairman, President and CEO of Teleflex.
"The ECG-only product and the range of navigation technologies that are under development will complement our ARROW VPS G4 system by diversifying and strengthening our PICC tip confirmation and navigation portfolio and enhance our ability to meet customer needs globally. Strategically, the addition of this technology will support Teleflex’s future expansion into tip confirmation for central venous catheters, chronic hemodialysis catheters and ports.
"We also gain access to an innovative product development pipeline, which includes integrated ultrasound capabilities that will extend our ability to offer differentiated catheter tip positioning solutions well into the future."
The financial terms of the transaction were not disclosed.
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers.
Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.